ethosuximide has been researched along with Bright Disease in 1 studies
Ethosuximide: An anticonvulsant especially useful in the treatment of absence seizures unaccompanied by other types of seizures.
ethosuximide : A dicarboximide that is pyrrolidine-2,5-dione in which the hydrogens at position 3 are substituted by one methyl and one ethyl group. An antiepileptic, it is used in the treatment of absence seizures and may be used for myoclonic seizures, but is ineffective against tonic-clonic seizures.
Bright Disease: A historical classification which is no longer used. It described acute glomerulonephritis, acute nephritic syndrome, or acute nephritis. Named for Richard Bright.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dormont, J | 1 |
| Sobel, A | 1 |
| Galanaud, P | 1 |
| Boelaert, J | 1 |
| Mery, JP | 1 |
| Richet, G | 1 |
1 other study available for ethosuximide and Bright Disease
| Article | Year |
|---|---|
[Exploration of cellular immunity during systemic lupus erythematosus].
Topics: Cell Migration Inhibition; DNA; Ethosuximide; Female; Glomerulonephritis; Humans; Immunity, Cellular | 1972 |